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Abstract
Objectives: Respiratory disease is a leading cause of morbidity and mortality worldwide. Most of the 
deaths will occur in low resource countries like Nigeria. There is limited data on the burden of these 
respiratory diseases.
Methods: A retrospective study of three hundred and seventy-seven (377) cases was carried out. Case 
selection was based on review by at least a specialist pulmonologist. Other data were retrieved with the 
help of questionnaire for analysis.
Results: Respiratory diseases accounted for about 10.4% of hospital admissions at the medical 
emergency of the hospital. Pulmonary tuberculosis (PTB) (40.3%) and acute lower respiratory tract 
infections (ALRTI) (27.9%) were the major presentation. More deaths occurred from PTB (51.6%), with 
HIV and diabetes mellitus been the major comorbidities commonly associated with the disease 
presentation. 
Conclusion: The burden of respiratory diseases is substantial, with communicable diseases such as PTB 
and ALRTI are leading in terms of inpatient presentation. HIV disease is the main condition commonly 
associated with morbidity and mortality. 
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Profils et évolution des maladies respiratoires chez les patients adultes 
hospitalisés à Abuja-Nigeria
Resume
Objectifs: Les maladies respiratoires sont l’une des principales causes de morbidité et de mortalité dans le 
monde. La plupart des décès surviendront dans des pays à faibles ressources telles que le Nigeria. Les 
données sur le fardeau de ces maladies respiratoires sont limitées.
Méthodes: Une étude rétrospective de trois cent soixante dix sept (377) cas a été réalisée. La sélection des 
cas était basée sur l'examen d'au moins un pneumologue spécialisé. D'autres données ont été récupérées à 
l'aide d'un questionnaire pour analyse.
Résultats: Les maladies respiratoires représentaient environ 10,4% des hospitalisations à l'urgence 
médicale de l'hôpital. La tuberculose pulmonaire (PTB) (40,3%) et les infections aiguës des voies 
respiratoires inférieures (ALRTI) (27,9%) constituaient la présentation principale. Les décès dus à la TBP 
étaient plus fréquents (51,6%), le VIH et le diabète sucré constituant les principales comorbidités 
couramment associées à la maladie.
Conclusion: le fardeau des maladies respiratoires est considérable. Les maladies transmissibles telles que 
la PTB et les ALRTI sont en tête en termes de présentation des patients hospitalisés. Le VIH est la 
principale affection couramment associée à la morbidité et à la mortalité.
Mots-clés: maladies respiratoires, fardeau, résultats
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INTRODUCTION
Respiratory diseases are responsible for 
a major burden of morbidity and mortality 
globally, with conditions such as tuberculosis and 
acute lower respiratory tract infections being the 
most important in world health terms (1). The 
increasing prevalence of allergy, asthma, chronic 
obstructive pulmonary disease (COPD) and lung 
cancers contributes to the overall burden of 
chronic respiratory disease in the community (2, 
3). This situation is made worse by the increasing 
number of cigarette smokers worldwide; 
ensuring a growing burden of tobacco-related 
respiratory conditions. The risk factor for 
developing these respiratory diseases are 
potentially preventable. Reduction in tobacco 
smoking, and improvement in the air quality 
indoor and at workplace are key to controlling 
these factors that are associated with reducing the 
burden of the respiratory diseases. An estimated 
65million, 334million, 10.4million,1.6million; 
suffer from COPD, asthma, tuberculosis and lung 
cancers respectively (3). The global impact of 
these main respiratory diseases is massive, 
devastating, and costly. They are the leading 
causes of death, disability, and suffering, 
especially in the most disadvantaged poor health 
resource countries (4). According to the World 
Health Organization estimates, respiratory 
diseases account for 9 million deaths (one-sixth 
of the global total) and one-tenth of the disability-
adjusted life-years (DALYs) lost worldwide (3). 
In addition to these common respiratory diseases 
there are several others like sleep-disordered 
breathing, pulmonary hypertension and 
occupational lung diseases whose burden are 
substantial but less well quantified. In most 
developing countries including Nigeria, the 
burden of respiratory disease is largely unknown; 
however, it appears to be on the increase (5). 
Respiratory infections, particularly TB and 
bacterial pneumonia, are the major causes of 
death in adults and children. (5). This study was 
designed to determine the prevalence and pattern 
of respiratory disease admission in a tertiary 




The study location was University of 
Abuja Teaching Hospital (UATH) Gwagwalada. 
The hospital is a tertiary health facility with 350 
bed spaces, located in one of the Federal Capital 
Territory (FCT) area council- Gwagwalada. 
Gwagwalada lies between 8° 56' 29" North and 7° 
5' 31" East. It has an area of 1,043 km².The 
Federal Capital Territory had a projected 
population of 1,406,239 inhabitants in the year 
2006, of which 157770 (11.22% approximately) 
inhabitants reside in Gwagwalada. The hospital 
provides health care services to the inhabitants of 
Abuja and neighboring states. 
Study design
This was a retrospective study conducted 
st stfrom 1  January 2016 to 31  December 2018 
(Thirty-six months).
Methods
A modified version of the chronic 
respiratory disease questionnaire (6) was used to 
obtain information on socio-demographic 
characteristics, comorbidities and respiratory 
symptoms of the patients.  Patient selection was 
based on history, physical examination and 
inves t igat ion  review by a  specia l i s t  
pulmonologist. Patients finally selected were 
those who are judged to have a respiratory 
medical condition. Three hundred and ninety-
eight cases were reviewed in the study. Three 
hundred and seventy-seven (377) met the 
inclusion criteria, twemty=one hospital folders 
had incomplete records and were eliminated in 
the final analysis. Those who had a confirmed 
respiratory disease and were managed defined 
outcome and either discharged home from the 
ward or died. 
Data Analysis 
Data from the retrieved questionnaires 
were coded, entered and analyzed using 
Statistical Package for Social Sciences (SPSS) 
version 20. Frequency distribution of variables 
were generated.  Independent and dependent 
variables were cross tabulated to determine 
degree of association. Comparison between 
different groups was done using Fisher's exact 
test, Pearson Chi-Square, Student t-test and test 
of correlation was performed using Spearman 
correlation test. Confidence interval was 95% 
and the p value less than 0.05 was considered 
significant.
RESULTS 
Out of the three hundred and ninety-eight 
(398) cases reviewed, three hundred and seventy- 
seven (377) of them met the selection criteria. 
The total number of patients admitted during the 
study period was three thousand, six hundred and 
eighty-six, which give a prevalence of respiratory 
diseases to be about 10.3%. There were more 
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women admitted than the men, with a male to 
female ratio of 1:12 the mean age of the study 
population was 44.4±16.5. The communicable 
and infectious diseases accounted for most of the 
respiratory conditions seen within this period. 
Pulmonary tuberculosis was the major 
presentation 40.3% (152), with nearly equal 
gender distribution and the mean age of 
presentation was 41.3±15.1 years, this is closely 
followed by pneumonia with a mean age of 
presentation of 46.4±18.1 years. Among the non-
communicable diseases Asthma and COPD were 
the predominant respiratory condition, with 
prevalence rates of 16.0% and 8.2% respectively. 
See table 1 for more details
In terms of the expected outcome, we 
recorded at least thirty-one deaths. More 
mortality occurred from pulmonary tuberculosis 
51.6% and Bronchogenic Carcinoma 16.1%. We 
report five (5) patients with bronchogenic 
Carcinoma; 4 of them had histologic diagnosis of 
alveolar cell carcinoma, mean age of presentation 
was 61 years, no history of cigarette smoke and 
all of them were women. We had one case of 
squamous cell carcinoma in a 49 years old man 
with 20 pack years of cigarette smoked.  table 2 
shows more details.
Table 3 shows a cross tabulation of 
morbidity of the respiratory disease and 
comorbidity. HIV/AIDS, Diabetes Mellitus and 
lung malignancy were the major comorbidities 
observed with frequency of 97 (25.7%), 17 
(4.5%) and 4(0.01%) of the overall cases 
reviewed. In a similar fashion HIV/AID was the 
most frequent comorbidity associated with 
pulmonary tuberculosis. (See table 3 for details)
DISCUSSION
Respiratory diseases contribute greatly 
to the health burden of the people. This is 
evidenced by the large proportion of medical 
emergencies which are of pulmonary origin. Our 
study found that 10.4% of medical emergencies 
were of respiratory origins. This is similar to a 
prevalence of 10.2% as recorded in another study 
done in same geographic location (7). 
The mean age of the study group was 
44.4±16.5years  with a  s l ight  female 
predominance which is comparable to “a M:F 
ratio of 1:1.2” which was however in contrast to 
the sex distribution of other studies which found a 
slight male predominance (7,9,10).  The reason 
for this may be as a result of improving health 
seeking behavior of females in our locality. 
Of the respiratory emergencies, the 
commonest were PTB (40.3%), pneumonia 
(27.9%), asthma (16.0%) and AECOPD (8.2%). 
Bronchogenic CA was the least (1.6%). The 
prevalence of PTB (40.3%) was similar to 66.8% 
found in a study in eastern-southern part of the 
country (11), which was also followed by 
pneumonia (24.9%), which again was close to our 
finding of 27.9%. PTB predominance were also 
noted elsewhere in India and Congo, 54.6% and 
52.08% respectively (9,12). This finding is not 
surprising as the communicable diseases and 
infections still predominate in sub-Saharan 
Africa where poverty, overcrowding play a major 
role in the distribution of diseases.  However, 
Desalu et al found a contrasting pattern in which 
there was pneumonia predominance with a 
prevalence of 34.5% followed by PTB (29.4%), 
asthma and AECOPD in that order (7). Whether 
this was as a result of his previous study in which 
he found that seasonal variations affect pattern of 
respiratory disease is unknown. He observed that 
during dry seasons there is pneumonia 
predominance (8). The frequency of non-
communicable diseases like COPD and lung 
cancer is still low in this region. This may be 
because we do not have screening facility, the 
capacity to make prompt and accurate diagnosis 
in most of our hospital.
Our study recorded 31 deaths which put 
the overall mortality rate at 8.2%. Twenty-four 
(24) hours mortality rates of 7.4% and 7.1% were 
also recorded in similar studies in the same 
geographical region (7,10). Whereas elsewhere, 
overall mortality was as high as 13.5% and 14.7% 
(8,11). PTB recorded the highest mortality of 
51.6%, followed by bronchogenic CA 16.1%. 
Both pneumonia and AECOPD showed rates of 
12.9%. The PTB mortality rate was higher than 
44.4% that was recorded in a previous study in the 
same location (7). Mortality rates as high as 
57.04% were recorded elsewhere (12). This 
shows that PTB is a major cause of mortality in 
our region and the world at large. This may be due 
to the reported coexistence of PTB with other 
chronic respiratory diseases which may not be 
immediately apparent at presentation (13). In this 
study, malignancy contributed the highest 
percentage of mortality among the non-
communicable diseases. This is not an unusual 
finding as most of them often present to our 
facility at the terminal stage of the disease after 
having tried many hospitals and or due to 
financial constraints. 
Of the comorbidities present, we 
observed that HIV was the commonest medical 
condition frequently associated with the patients. 
This was followed by DM and lastly Malignancy. 
HIV predominant coexistence with respiratory 
diseases is of importance as it causes increased 
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mortality on the patients. Other studies also noted 
HIV as the commonest comorbidity in respiratory 
diseases (10,11,12). Respiratory diseases were 
predicted to occur more in HIV patients 
especially with reducing CD4 count (14).
It is worthy of note that 74.2% of the HIV 
comorbidities were associated with PTB. This 
buttresses the fact that there is high incidence of 
HIV/PTB coexistence and this ultimately yields 
higher mortality (15,16). 
CONCLUSION
Respiratory diseases contribute ample 
percentage of medical in-patient admissions. Of 
the respiratory morbidity, PTB is the most 
occurring in our center and is often associated 
with HIV comorbidity. The resultant effect is a 
high patient mortality rate in those group of 
patients. Therefore, high index of suspicion of 
PTB/HIV coexistence must be applied in the 
respiratory emergency room to ensure early 
diagnosis and prompt institution of appropriate 
treatment to avert mortality. Finally, more 
resources and future research should be directed 
at combatting the risk factors of these diseases.
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SD= standard deviation, AECOPD= acute exacerbation of chronic obstructive pulmonary disease,  
CA = carcinoma, n= frequency  
Diagnosis   Age mean (SD) Female n (%) Male n (%) Total n (%) 
Pneumonia  46.4±18.1 57 (28.6%) 48 (27.4) 105 (27.9%) 
Pulmonary tuberculosis 41.3± 15.1 78 (38.6%) 74 (42.3%) 152 (40.3%) 
Acute severe asthma 40.0±16.0 33 (16.3%) 27 (15.4%) 60 (16.0%) 
AECOPD 57.8± 13.5 13 (6.4%) 18 (10.3%) 31 (8.2%) 
Pleural effusion 44.2±12.5 11 (5.4%) 6 (3.4%) 17 (4.5%) 
Bronchogenic CA 60.7± 10.2 4 (2.0%) 2 (1.1%) 6 (1.6%) 
Pulmonary embolism 42.2±10.1 6 (3.0%) 0 (0.0) 6 (1.6%) 
Total 44.4±16.5 202(53.6) 175(46.4) 377(100%) 
  
Table 2: Diagnosis of in-patients and outcome 
Diagnosis   Discharged n (%)   
Died n (%)   
 
Total n (%) 
Pneumonia  101 (29.2) 4 (12.9) 105(27.9) 
Pulmonary tuberculosis 136 (39.3) 16 (51.6) 152 (40.3) 
Acute severe asthma 59 (17.1) 1 (3.2) 60 (15.9) 
AECOPD 27 (7,8) 4 (12.9) 31 (8.2) 
Pleural effusion 16 (4.6) 1 (3.2) 17 (4.5) 
Bronchogenic CA 1 (0.3) 5 (16.1) 6 (1.6) 
Pulmonary Embolism 6 0 6 (1.6) 
Total  346 (91.8) 31 (8.2) 377 (100) 
Table 3: Table showing comonly asociated comorbidity with respiratory disease  
 
Diagnosis   HIV/ AIDS (%)  DM (%)   Malignancy (%) Total (%) 
Pneumonia  16 (16.5) 11 (64.7) - 27(27.9) 
Pulmonary tuberculosis 72 (74.2) 5 (29.4) - 77 (40.3) 
Acute severe asthma 7(7.2) 1 (5.9) - 8 (6.8) 
AECOPD 1 (1.0) 4 (12.9) 1 2 (1.7) 
Pleural effusion 1(1.0) 0(0) 3 4(3.4) 
Total  97 17 4 118(100) 
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